EQ (Equillium) Short Interest


EQ Equillium Inc EQ
28 GF Score
Price $2.86
GF Value $0.10
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Equillium Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

EQ vs MDWD, DTIL, TLSA: Short Interest Comparison

For the Biotechnology subindustry, Equillium's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Equillium Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Equillium's Short Interest distribution charts can be found below:

* The bar in red indicates where Equillium's Short Interest falls into.


EQ
28GF Score
Equillium Inc EQ
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Equillium (EQ) Overvalued in 2026?

Based on GuruFocus' analysis, Equillium stock appears to be overvalued. The current stock price of $2.86 is trading 2760% above its estimated GF Value™ of $0.10. GuruFocus considers Equillium to be Significantly Overvalued.

Key valuation signals for EQ:

  • Short Interest:
  • GF Value™: $0.10 vs. price of $2.86 (2760% above fair value)
  • GF Score™: 28/100 with 3 warning signs

No single metric tells the full story. See the EQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Equillium Business Description

Other Exchanges 0A4D:UK0FY:Germany
Address 2223 Avenida De La Playa, Suite 105, La Jolla, CA, USA, 92037
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
28GF Score

Get the complete analysis for EQ

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.86
Price
$0.10
GF Value